Prognostic factors in colorectal cancer - Literature review for clinical application

被引:122
作者
Ratto, C [1 ]
Sofo, L [1 ]
Ippoliti, N [1 ]
Merico, M [1 ]
Doglietto, GB [1 ]
Crucitti, F [1 ]
机构
[1] Catholic Univ, Dept Clin Chirurg, I-00168 Rome, Italy
关键词
colorectal cancer; prognosis; survival; tumor stage; lymph node involvement; distant metastases; bowel obstruction; univariate analysis; multivariate analysis;
D O I
10.1007/BF02237397
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Identification of prognostic factors is a primary basis for planning the treatment and predicting the outcome of patients with colorectal cancer. Reviewing studies from the literature performed using univariate and multivariate analyses and their own study, the authors critically discuss the prognostic value of the clinicopathologic parameters of the tumor. METHODS: Among 853 patients with colorectal tumors seen at the Department of Clinical Surgery of the Catholic University of Rome, Italy, 690 cases that were curatively resected entered the study. Overall survival rate, related to the clinicopathologic variables, was calculated, and univariate and multivariate analyses were per formed. RESULTS: Five-year and ten-year overall survival rates were 70 and 55 percent, respectively. Univariate and multivariate analyses showed that node involvement, distant metastases, bowel obstruction, and patient gender are factors independently related to outcome. CONCLUSIONS: Data from the literature and the present study suggest that only a few clinical parameters, particularly bowel obstruction, and some pathologic factors (tumor stage, vessels invasion, and tumor ploidy) are related to patient survival rate and are the most reliable prognostic criteria. In prospective clinical studies, any other new pathologic or molecular factors should be matched with these parameters to confirm their value in outcome prediction.
引用
收藏
页码:1033 / 1049
页数:17
相关论文
共 158 条
  • [91] MURRAY D, 1975, ARCH SURG-CHICAGO, V110, P908
  • [92] NEWLAND RC, 1994, CANCER, V73, P2076, DOI 10.1002/1097-0142(19940415)73:8<2076::AID-CNCR2820730811>3.0.CO
  • [93] 2-6
  • [94] OBRIEN MJ, 1988, BR J MED SCI, V157, P5
  • [95] OCONNELL MJ, 1992, CANCER-AM CANCER SOC, V70, P1732, DOI 10.1002/1097-0142(19920915)70:4+<1732::AID-CNCR2820701614>3.0.CO
  • [96] 2-#
  • [97] ONETTO M, 1985, BIOMED PHARMACOTHER, V39, P392
  • [98] OSNES S, 1956, Acta Chir Scand, V110, P378
  • [99] Prognostic markers for colorectal cancer: Expression of P53 and BCL2
    Pereira, H
    Silva, S
    Juliao, R
    Garcia, P
    Perpetua, F
    [J]. WORLD JOURNAL OF SURGERY, 1997, 21 (02) : 210 - 213
  • [100] p53 and Rb1 protein expression: Are they prognostically useful in colorectal cancer?
    Poller, DN
    Baxter, KJ
    Shepherd, NA
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (01) : 87 - 93